Brokerages Set $16.00 Target Price for IntriCon Corporation (IIN)

Shares of IntriCon Corporation (NASDAQ:IIN) have been given an average broker rating score of 2.50 (Hold) from the two analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating and one has given a buy rating to the company.

Analysts have set a 1 year consensus price objective of $16.00 for the company and are expecting that the company will post $0.08 earnings per share for the current quarter, according to Zacks. Zacks has also given IntriCon an industry rank of 69 out of 265 based on the ratings given to related companies.

A number of research analysts recently issued reports on the stock. Zacks Investment Research cut shares of IntriCon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 4th. TheStreet raised shares of IntriCon from a “c” rating to a “b-” rating in a research note on Wednesday, November 8th. Finally, Longbow Research reaffirmed a “neutral” rating on shares of IntriCon in a research note on Friday, August 25th.

In other news, VP Michael Geraci sold 2,737 shares of IntriCon stock in a transaction on Monday, November 27th. The shares were sold at an average price of $17.60, for a total transaction of $48,171.20. Following the transaction, the vice president now owns 22,011 shares in the company, valued at $387,393.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 21.40% of the stock is currently owned by insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Heartland Advisors Inc. lifted its holdings in IntriCon by 0.6% in the second quarter. Heartland Advisors Inc. now owns 809,499 shares of the technology company’s stock valued at $6,618,000 after buying an additional 4,622 shares during the period. Pacific Alternative Asset Management Company LLC lifted its holdings in IntriCon by 73.4% in the second quarter. Pacific Alternative Asset Management Company LLC now owns 292,853 shares of the technology company’s stock valued at $2,394,000 after buying an additional 123,942 shares during the period. Renaissance Technologies LLC raised its holdings in shares of IntriCon by 6.0% during the first quarter. Renaissance Technologies LLC now owns 184,899 shares of the technology company’s stock valued at $1,683,000 after purchasing an additional 10,499 shares during the period. EAM Investors LLC acquired a new position in shares of IntriCon during the third quarter valued at about $588,000. Finally, Algert Global LLC acquired a new position in shares of IntriCon during the third quarter valued at about $396,000. Institutional investors and hedge funds own 33.89% of the company’s stock.

Shares of IntriCon (NASDAQ IIN) traded down $0.20 on Friday, hitting $17.35. 34,310 shares of the stock traded hands, compared to its average volume of 62,375. IntriCon has a 12 month low of $5.90 and a 12 month high of $17.80. The company has a market capitalization of $119.18, a PE ratio of 192.78, a PEG ratio of 3.34 and a beta of 0.31. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.45 and a quick ratio of 0.54.

COPYRIGHT VIOLATION WARNING: This report was originally published by American Banking News and is the property of of American Banking News. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/12/03/brokerages-set-16-00-target-price-for-intricon-corporation-iin.html.

IntriCon Company Profile

IntriCon Corporation is engaged in designing, developing, engineering, manufacturing and distributing body-worn devices. The Company operates through body-worn device segment. The Company serves the body-worn device market by designing, developing, engineering and manufacturing micro-miniature products, microelectronics, micro-mechanical assemblies, complete assemblies and software solutions, primarily for the value hearing health market, the medical bio-telemetry market and the professional audio communication market.

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for IntriCon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply